Migros has announced a series of steps in its plan to bundle its supermarket business into a centrally managed stand-alone company, Migros Supermarkt. This business represented CHF 12 billion in revenues by 2022. Migros Supermarkt is scheduled
Tags :Homburger
As part of a strategic reorganization, the American cotton manufacturer U.S. Cotton has sold the Flawil-based producer of absorbent cotton and other products, FLAWA Consumer, to members of its management. Homburger advised U.S.
Evolva Holding announced that it had entered into a new agreement with Nice & Green (N&G) to replace an existing an equity-linked debt instrument issued by Evolva consisting of convertible notes issued in
Santhera Pharmaceuticals Holding has announced the grant of an exclusive North America license for the commercialization of vamorolone to Catalyst Pharmaceuticals for a total consideration of up to USD 231 million
Bunge has entered into a definitive agreement with Viterra, a private company limited by shares incorporated under the laws of Jersey, together with certain affiliates of Glencore, Canada Pension Plan Investment Board and British Columbia
On June 8, 2023, Zürcher Kantonalbank has successfully completed its inaugural EUR Bail-in Bond issuance in the amount of EUR 500 million. ZKB’s Bail-in Bonds are novel instruments which have been designed and issued on the
UBS, acting through its London branch, successfully completed its issuance of (i) CHF 310 million aggregate principal amount of 2.385 per cent. Notes due 2025, and (ii) CHF 150 million aggregate principal amount of 2.550 per cent. Notes due 2029, in
K-Fee System has sued Nestlé Nespresso for infringement of three European patents. K-Fee belongs to the Krüger group of companies. The group has recently partnered with Coca-Cola in the coffee pod business with the
Homburger acted as Swiss counsel to AtlasEdge, a renowned pan-European Edge data centre provider, on a scalable EUR 725 m loan financing. The financing was underwritten by mandated lead arranger ING Bank, as well as ABN
Ironwood Pharmaceuticals (Nasdaq: IRWD), a healthcare company specializing in GI treatments, and VectivBio Holding (Nasdaq: VECT), a clinical-stage biopharmaceutical company focused on developing innovative therapies for severe rare gastrointestinal conditions, have reached an agreement where&
